CAPPED BONUSZERTIFIKAT - MERCK & CO. Stock

Certificat

DE000PC1UZ11

Market Closed - Boerse Frankfurt Warrants 15:40:09 2024-05-31 EDT
99.52 EUR +0.17% Intraday chart for CAPPED BONUSZERTIFIKAT - MERCK & CO.
Current month-1.31%
1 month-1.31%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-05-31 99.52 +0.17%
24-05-30 99.35 -0.61%
24-05-29 99.96 +0.56%
24-05-28 99.4 -0.39%
24-05-27 99.79 -0.01%

Real-time Boerse Frankfurt Warrants

Last update May 31, 2024 at 03:40 pm

More quotes

Static data

Product typeCertificats Bonus
Buy / SellCALL
Underlying MERCK & CO., INC.
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PC1UZ1
ISINDE000PC1UZ11
Date issued 2023-12-13
Strike 120 $
Maturity 2025-12-19 (566 Days)
Parity 1 : 1
Emission price 87.91
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 101
Lowest since issue 90.58
Spread 0.02
Spread %0.02%

Company Profile

Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows: - sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.; - sale of vaccines (18%); - sale of animal health products (9.4%); - other (2.9%). Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
More about the company

Ratings for Merck & Co., Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Merck & Co., Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
27
Last Close Price
125.5 USD
Average target price
141.9 USD
Spread / Average Target
+13.01%
Consensus